These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 15667793)
1. Proteomic analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in leukemia K562 cells. Wang ZH; Yu D; Chen Y; Hao JZ Chin Med J (Engl); 2005 Jan; 118(2):100-4. PubMed ID: 15667793 [TBL] [Abstract][Full Text] [Related]
2. Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment. Wang ZH; Yu D; Li HK; Chow VW; Ng CC; Chan HB; Cheng SB; Chew EC Anticancer Res; 2001; 21(1A):493-8. PubMed ID: 11299786 [TBL] [Abstract][Full Text] [Related]
3. [Proteome analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in K562 cells]. Wang ZH; Yu D; Zheng J; Chen Y Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):163-6. PubMed ID: 15841146 [TBL] [Abstract][Full Text] [Related]
4. The effect of arsenic trioxide on the expression of Hsc and HNF4 in nuclear matrix proteins in HepG2 cells. Yu D; Wang ZH; Cheng SB; Li HK; Chan HB; Chew EC Anticancer Res; 2001; 21(4A):2553-9. PubMed ID: 11724321 [TBL] [Abstract][Full Text] [Related]
5. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia. Sahu GR; Jena RK Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419 [TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B; Yang X; An L; Gao B; Liu X Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms. Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676 [TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells. Zhou C; Boggess JF; Bae-Jump V; Gehrig PA Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888 [TBL] [Abstract][Full Text] [Related]
11. Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell. Du CW; Wen BG; Li DR; Lin YC; Zheng YW; Chen L; Chen JY; Lin W; Wu MY Exp Oncol; 2005 Dec; 27(4):267-72. PubMed ID: 16404345 [TBL] [Abstract][Full Text] [Related]
12. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines. Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines. Wei YM; Ou YX; Bai H; Lu JH; Zheng RL Acta Pharmacol Sin; 2001 Aug; 22(8):725-30. PubMed ID: 11749846 [TBL] [Abstract][Full Text] [Related]
14. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells. Chan JY; Siu KP; Fung KP Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide. Deng Y; Lin C; Zheng J; Fu M; Liang X; Chen J; Xiao P; Wu M Chin Med J (Engl); 2000 Jan; 113(1):84-8. PubMed ID: 11775218 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [TBL] [Abstract][Full Text] [Related]
17. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide. Wang X; Wang G; Dong D; Fu S; Yang B Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528 [TBL] [Abstract][Full Text] [Related]
18. BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity. Puccetti E; Güller S; Orleth A; Brüggenolte N; Hoelzer D; Ottmann OG; Ruthardt M Cancer Res; 2000 Jul; 60(13):3409-13. PubMed ID: 10910048 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells. Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472 [TBL] [Abstract][Full Text] [Related]
20. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]